Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.

Appl Health Econ Health Policy

Institute of Mathematical Sciences and Physics, Mathematics Building, University of the Philippines Los Baños, Jose R. Velasco Avenue, Los Baños City, 4031, Philippines.

Published: September 2021

Background: Vaccine allocation is a national concern especially for countries such as the Philippines that have limited resources in acquiring COVID-19 vaccines. As such, certain groups are suggested to be prioritized for vaccination to protect the most vulnerable before vaccinating others.

Objective: The study aims to determine an optimal and equitable allocation of COVID-19 vaccines in the Philippines that will minimize the projected number of additional COVID-19 deaths while satisfying the priority groups for immediate vaccination.

Methods: In this study, a linear programming model is formulated to determine an allocation of vaccines such that COVID-19 deaths are minimized while the prioritization framework set by the government is satisfied. Data used were collected up to November 2020. Total vaccine supply, vaccine effectiveness, vaccine cost, and projected deaths are analyzed. Results of the model are also compared to other allocation approaches.

Results: Results of the model show that a vaccine coverage of around 60-70% of the population can be enough for a community with limited supplies, and an increase in vaccine supply is beneficial if the initial coverage is less than the specified target range. Additionally, among the vaccines considered in the study, the one with 89.9% effectiveness and a 183 Philippine peso price per dose projected the lowest number of deaths. Compared with other model variations and common allocation approaches, the model has achieved both an optimal and equitable allocation.

Conclusions: Having a 100% coverage for vaccination with a 100% effectiveness rate of vaccine is ideal for all countries. However, some countries have limited resources. Therefore, the results of our study can be used by policymakers to determine an optimal and equitable distribution of COVID-19 vaccines for a country/community.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225461PMC
http://dx.doi.org/10.1007/s40258-021-00667-zDOI Listing

Publication Analysis

Top Keywords

covid-19 vaccines
16
optimal equitable
12
allocation covid-19
8
vaccines philippines
8
limited resources
8
determine optimal
8
covid-19 deaths
8
vaccine supply
8
vaccine
7
allocation
6

Similar Publications

Objective: To analyze the determinants for non-vaccination against COVID-19 in pregnant women in Belo Horizonte, Minas Gerais, Brazil.

Methods: An epidemiological study with a cross-sectional design was conducted using data from the project titled "Childbirth and Breastfeeding in Children of Mothers Infected by SARS-CoV-2," developed during the pandemic in the city of Belo Horizonte, Minas Gerais, Brazil.

Results: The study sample consisted of 360 pregnant women, of whom 77.

View Article and Find Full Text PDF

Dynamics and triggers of misinformation on vaccines.

PLoS One

January 2025

Centro Ricerche Enrico Fermi, Rome, Italy.

The Covid-19 pandemic has sparked renewed attention to the risks of online misinformation, emphasizing its impact on individuals' quality of life through the spread of health-related myths and misconceptions. In this study, we analyze 6 years (2016-2021) of Italian vaccine debate across diverse social media platforms (Facebook, Instagram, Twitter, YouTube), encompassing all major news sources-both questionable and reliable. We first use the symbolic transfer entropy analysis of news production time-series to dynamically determine which category of sources, questionable or reliable, causally drives the agenda on vaccines.

View Article and Find Full Text PDF

Building a Fast Response Capability for Emerging Infectious Diseases Within the Biomedical Advanced Research and Development Authority.

Health Secur

January 2025

Robert A. Johnson, PhD, is Director, Medical Countermeasures Programs, and Gary L. Disbrow, PhD, is Director, Center for Biomedical Advanced Research and Development Authority (BARDA), Washington, DC. Terence M. Barnhart, PhD, is Senior Strategy Implementation Leader, Tunnell Government Services, Inc. (Contractor Supporting BARDA), Washington, DC.

From influenza to COVID-19, emerging infectious diseases have taken a heavy toll on lives and resources. Emerging infectious diseases represent one of the largest threats to national security. The primary mission of the Center for Biomedical Advanced Research and Development Authority (BARDA), within the US Administration for Strategic Preparedness and Response, is to support the advanced development of medical countermeasures (MCMs) for public health security threats, including select infectious diseases.

View Article and Find Full Text PDF

Objective: To document the actions taken by Brazil's National Immunization Program for the pharmacovigilance of COVID-19 vaccines.

Methods: Documentary research on the period 2020 to 2023. Documentary sources from the national Ministry of Health during COVID-19 vaccination were used to analyze and interpret the actions taken.

View Article and Find Full Text PDF

Objectives: We assessed the transmission of SARS-CoV-2 and vaccine receipt in a representative sample of wet market workers in a highly dense, low-income setting. Wet markets are key in many Asian settings, including Dhaka, Bangladesh, for fresh food, including animal protein.

Methods: During early 2022, we assessed the prevalence of anti-SARS-CoV-2 antibodies in a random sample of poultry and vegetable workers in 15 wet markets, and investigated associations with socio-demographic characteristics and COVID-19 vaccination.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!